Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2025 · 10-Q
Revenue$16.07M$16.07M−37.8% vs Q2 2024 Net Income-$1.49M-$1.49MN/M vs Q2 2024 EPS Diluted-$0.05-$0.05N/M vs Q2 2024 Gross Profit$2,503,000−45.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,844,000+27.9% Free Cash Flowderived$1,680,000+45.3% Margins · derivedGross margin15.6%−2.0 pt vs Q2 2024
Operating margin-8.4%−10.4 pt vs Q2 2024
Net margin-9.3%−10.6 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end